State Cannabis Legalization and Psychosis-Related Health Care Utilization
This article originally appeared at https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800728 Authors: Holly Elser, MD, PhD1,2; Keith Humphreys, PhD3,4; Mathew V. Kiang, ScD5; et alSwapnil Mehta, MD4; Jong H. Yoon, MD4,6; William O. Faustman, PhD4,6; Ellicott C. Matthay, PhD7 JAMA Netw Open. 2023;6(1):e2252689. doi:10.1001/jamanetworkopen.2022.52689 Key Points Question Is state cannabis legalization or commercialization associated with increased rates of psychosis-related health care claims? Findings In this cohort study of claims data from 63 680 589 beneficiaries from […]
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment
This article originally appeared at https://jamanetwork.com/journals/jamaoncology/article-abstract/2799132 Yuhua Bao, PhD1,2; Hao Zhang, PhD1; Eduardo Bruera, MD3; et alRussell Portenoy, MD4,5,6; William E. Rosa, PhD, MBE, APRN7; M. Carrington Reid, MD, PhD8; Hefei Wen, PhD9 JAMA Oncol. 2023;9(2):206-214. doi:10.1001/jamaoncol.2022.5623 Key Points Question Is medical marijuana legalization associated with opioid-related and pain-related outcomes for adult patients newly diagnosed with cancer and receiving anticancer treatment? Findings This cross-sectional study of 38 189 patients with […]
